Status:
COMPLETED
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Pancreatic Cancer
Neoadjuvant
Eligibility:
All Genders
Brief Summary
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Detailed Description
The 1,132 patients with resectable or borderline resectable PDAC who underwent surgery between 2007 and 2021 were retrospectively reviewed. Patients with resectable PDAC without contact of major vesse...
Eligibility Criteria
Inclusion
- Patients diagnosed with resectable or borderline resectable pancreatic ductal adenocarcinoma (PDAC)
- Between January 2007 and June 2021 at Seoul National University Hospital
Exclusion
- Patients who had borderline resectable PDAC with arterial invasion
- Patients who received chemotherapy as initial treatment and did not undergo surgery
- Incomplete follow-up data for analysis
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
1132 Patients enrolled
Trial Details
Trial ID
NCT06129812
Start Date
January 1 2007
End Date
December 1 2021
Last Update
November 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.